盘龙药业：中药配方颗粒已备案411个品种

Core Viewpoint - The company is focusing on traditional Chinese medicine formula granules as its second growth curve, with significant progress in product registration and market expansion [1] Group 1: Product Registration and Market Expansion - The company has completed national registration for 411 varieties of traditional Chinese medicine formula granules [1] - The first batch of 111 varieties has been listed at controlled prices in nine provinces, including Shaanxi, Beijing, and Shandong [1] - The second batch of 100 varieties is currently in the process of application [1] Group 2: Sales Strategy - The company employs a combination of self-operated teams and agents for its sales strategy [1] - In Shaanxi province, the company has developed over 20 secondary hospitals and is steadily advancing its national recruitment layout [1]